The feasibility of the concept is demonstrated
by a set of experimental data. Furthermore, it is
demonstrated that physiological limitations of short-term and
long-term excretion of glycolate can be circumvented by the use
of genetically modified algal cells, i.e. specific mutants of Chlamydomonas
reinhardtii.